NCT06115174 2023-11-02
CRC - PTX
Tanta University
Phase 4 Unknown
Clinical Trials
28 trialsNCT00958737 2023-09-29
IDEA
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Unknown
NCT04659382 2023-08-18
SIRTCI
Federation Francophone de Cancerologie Digestive
Phase 2 Unknown
NCT05715632 2023-07-14
New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
Tang-Du Hospital
Phase NA Unknown
NCT05420584 2023-05-11
NECI
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 2 Unknown
NCT04522284 2023-03-29
PRECISE CURATE.AI Pilot Clinical Trial
National University Hospital, Singapore
Phase 1/2 Unknown
NCT04744649 2022-11-15
NICE
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT05545436 2022-09-22
Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown
NCT05468138 2022-08-26
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
Fudan University
Phase 2 Unknown
NCT05193292 2022-01-14
Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT02934464 2021-09-13
ARMANI
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 3 Unknown
NCT03484221 2021-04-14
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
China Medical University, China
Phase 2 Unknown
NCT04416854 2020-06-04
The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
Fudan University
Phase 3 Unknown
NCT03229096 2019-06-28
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT03511170 2018-05-01
XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Harbin Medical University
Phase 2 Unknown
NCT03511183 2018-05-01
XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Harbin Medical University
Phase 2 Unknown
NCT03399253 2018-01-16
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor
Sun Yat-sen University
Phase 2/3 Unknown
NCT03355612 2017-11-28
XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT02356276 2017-10-31
EHTLAGCRGD2
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Unknown
NCT03038217 2017-02-03
Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT02912052 2016-09-23
PEPCORLI
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Unknown
NCT02870153 2016-08-19
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
The First People's Hospital of Changzhou
Phase 2 Unknown
NCT02777437 2016-05-19
Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer
Fudan University
Phase 2/3 Unknown
NCT01618474 2015-12-22
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT02590367 2015-12-02
Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy
Jiangsu Province Hospital of Traditional Chinese Medicine
Phase 2/3 Unknown
NCT02291744 2015-11-11
A Phase â…¡ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients
Fudan University
Phase 2 Unknown
NCT02075086 2015-03-17
ANGIOSWITCH
Grupo Hospital de Madrid
Phase 2 Unknown
NCT00997685 2009-10-19
Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)
Guangdong Provincial People's Hospital
Phase 2 Unknown